Diaceutics to attend Stifel Conference in NYC

Diaceutics PLC

30 November 2023

 

Diaceutics to attend Stifel and LSE 'Best of British' Conference in NYC

Belfast and London, 30 November 2023 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharmaceutical and biotech industry, announces that management will attend the Stifel 5^th Annual 'Best of British' Discovery Conference at the London Stock Exchange's NYC offices on 13 December 2023.

Enquiries: 

Diaceutics PLC
Peter Keeling, Chief Executive Officer	Tel: [phone]
Ryan Keeling, Chief Executive Officer Designate	[e-mail]
Nick Roberts, Chief Financial Officer
Stifel Nicolaus Europe Limited (Nomad & Broker)	Tel: [phone]
Ben Maddison
Nick Harland
Kate Hanshaw
Alma Strategic Communications	Tel: [phone]
Caroline Forde	[e-mail]
Matthew Young
Kinvara Verdon

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.

We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®

 

END